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A B S T R A C T
Solitary fibrous tumors/hemangiopericytomas (SFT/HPC) are soft tissue tumors that can arise
from the abdomen, pleura, head and neck, or extremities.We report an unusual case of re-
current hemangiopericytoma in a 67-year-old female presenting with a painless and palpable
mass within her right posterior neck. Eight years after initial resection of the mass, a follow-
up MRI showed multiple enlarging calvarial lesions. A whole body FDG-PET/CT revealed not
only hypermetabolic calvarial lesions but also numerous hypermetabolic axillary node and
osseous metastases. Though the majority of these soft tissue tumors exhibit benign be-
havior and carry a favorable prognosis, patients with these slow growing tumors are at risk
for local recurrence and distant metastases which demonstrate substantial FDG avidity. Ad-
ditional studies are needed to clarify the role of whole body FDG-PET/CT in the surveillance
of SFT/HPC to detect recurrent or metastatic lesions.
© 2018 the Authors. Published by Elsevier Inc. under copyright license from the University
ofWashington. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
Hemangiopericytoma or solitary fibrous tumors (SFT/HPC) are
rare mesenchymal tumors that often present as a painless mass
most commonly arising from the abdomen and pleura, though
they can also be found in the extremities, head and neck or
trunk, and central nervous system. Although the majority of
these tumors exhibit benign behavior and have a good prog-
nosis, physicians must be aware that a minority of patients
with these slow-growing tumors are at risk for local recur-
rence and distant metastases [1–3]. Here, we present an unusual
case of cervical paravertebral SFT/HPC with both local
recurrence and widespread metastatic disease detected by
fluorodeoxyglucose positron emission tomography-computed
tomography (FDG-PET/CT).
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Case report
A healthy 67-year-old female presented to her primary care phy-
sician with a painless mass in her right posterior neck. A
magnetic resonance imaging (MRI) of the cervical spine showed
a paravertebral soft tissue mass (Fig. 1), which was resected
in February 2007 and treated with adjuvant radiation.
Pathological examination revealed a highly cellular spindle cell
neoplasm with frequent staghorn vessels and thick bands of
collagen accompanied by scattered multinucleated giant cells,
which was diagnosed as a hemangiopericytoma (HPC). Sub-
sequent staging computed tomography (CT) of the chest,
abdomen, and pelvis at the time showed no other sites of in-
volvement. Serial surveillance MRI scans of the cervical spine
were ordered from 2008 to 2014, which showed minimally en-
hancing scar tissue and post-treatment changes in the neck,
but no newmass-like areas of enhancement or cervical lymph-
adenopathy suspicious for recurrence or local metastases.
However, an MRI of the cervical spine performed on April
2015 revealed 3 new nodules within the right posterior occipi-
tal calvarium measuring up to 9 mm in diameter (Fig. 2)
suspicious for local metastases. A review of prior studies re-
vealed that in retrospect, these slow-growing nodules were
present on an earlier MRI from February 2013. In June 2015, she
underwent a resection of the calvarial lesions and pathology
confirmed recurrent HPC.Microscopic examination also showed
that the tumor demonstrated increased nuclear pleomor-
phism and a mitotic index that had increased from 1 mitosis
to 5 mitoses per high-powered field, consistent with a Ki-67
index of 8%-10%. Additionally, a STAT6 immunohistochemi-
cal stain demonstrated strong nuclear staining, consistent with
a diagnosis of recurrent SFT/HPC with increasedmitotic activity.
Given the recurrent nature of her malignancy, the patient
underwent a staging whole body FDG-PET/CT, which showed
distant metastases, including numerous hypermetabolic me-
tastases within the right axillary lymph nodes and bony pelvis
involving the right acetabulum, right sacrum, and left poste-
rior iliac bone (Fig. 3) as well as multiple hypermetabolic, ovoid,
and variably lytic or sclerotic lesions within the calvarium
(Fig. 4).
Discussion
Hemangiopericytomas (HPC) have historically represented a dif-
ficult pathologicdiagnosis given the substantial histologic overlap
with solitary fibrous tumors (SFT) as well as synovial sarco-
mas [4,5]. However, recent studies have shown that HPC and
SFT arise from the same inciting mutation, specifically, an in-
version at 12q13 with a fusion of the NAB2 and STAT6 genes
resulting in nuclear expression of STAT6 that can be detected
by immunohistochemistry.These findings confirm thatHPC and
SFT, previously thought to be unique tumors, are essentially
equivalent entities with varying histology and aggressiveness
[6,7]. This has resulted in a complicated nomenclature, with
soft tissue pathologists favoring the term solitary fibrous tumor
while neuropathologists prefer the term hemangiopericytoma
when such tumors arise from the central nervous system (CNS)
given the clinical implications of the term, including high rates
of recurrent disease and risk of distantmetastasis many years
after initial resection, as seen in this case [8].
Although soft tissue pathologists now exclusively utilize the
term SFT, neuropathologists have grouped these two entities
together under the term solitary fibrous tumor/hemangiopericytoma
and created a unique grading system that has been reflected
in the 2016 update to the World Health Organization Classi-
fication ofTumors of the CNS.A grade I SFT/HPC is characterized
by a spindle cell lesion with abundant collagen whereas lesions
accompanied by “staghorn” vasculature represent a grade II SFT/
HPC and can also be referred to as a hemangiopericytoma.
Tumors characterized by high mitotic activity (5 + mitoses/
Fig. 1 – Noncontrast enhanced computed tomography
demonstrating original appearance of patient’s posterior
cervical neck mass.
Fig. 2 – Calvarial lesions representing metastatic
hemangiopericytoma or solitary fibrous tumors seen on
contrast-enhanced T1-weighted brain magnetic resonance
imaging.
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high-powered field) meet criteria for grade III SFT/HPC also
known as an anaplastic hemangiopericytoma [8].
In this particular case, though diagnosed as an HPC at initial
presentation, the tumor appears to be confined to the para-
vertebral soft tissue without CNS involvement and would likely
be labeled an SFT under the current terminology. Following
recurrence of her SFT/HPC many years later, the histology of
her tumor had changed significantly, with greater than 5
mitoses per high powered field and involvement of the cal-
varium. Though increased mitotic activity is associated with
more aggressive clinical behavior [1–3], even low-grade tumors
with bland histology have malignant potential and require sur-
veillance for distant metastases [9].
Treatment for these tumors primarily consists of surgical
resection.They often carry a relatively favorable prognosis, with
5- and 10-year disease-specific survival rates of 89% and 73%
respectively andmetastasis-free survival rates at 5 and 10 years
estimated at 74% and 55%, respectively [1]. More recent
population-based estimates for 5-, 10-, and 20-year disease-
specific survival for SFT/HPCs arising specifically from the head
and neck are similar, 84.0%, 79.4%, and 69.4% respectively. Ad-
juvant chemotherapy, although not uncommon, remains
controversial as studies have failed to demonstrate a surviv-
al benefit. However, as this case and prior studies have
illustrated, 10%-20% of these tumors demonstrate aggressive
behavior and develop local recurrence as well as distant me-
tastases years after initial diagnosis [1,10].
Though SFT/HPCs are uncommon, this case demonstrates
the need for physicians to be aware of the malignant and re-
current potential of these tumors.The slow-growing nature of
these lesions can make local recurrence difficult to detect on
CT or MRI, especially when set within a background of post-
surgical changes. Other case reports have also shown that SFT/
HPCs with recurrent/metastatic lesions can demonstrate
substantial FDG avidity [11,12]. One study with limited sample
Fig. 3 – Fluorodeoxyglucose positron emission tomography-computed tomographyimages. (A) MIP (maximum Intensity
Projection) whole body FDG image demonstrating hypermetabolic osseous and soft tissue metastases. (B) FDG, (C) hybrid,
and (D) computed tomography (CT) images demonstrating a hypermetabolic sclerotic left iliac bone metastasis. (E) FDG, (F)
hybrid, and (G) CT images demonstrating an enlarged hypermetabolic right axillary lymph node suspicious for metastases.
Fig. 4 – Head computed tomography showing lytic and
sclerotic lesions within the calvarium with associated
hypermetabolism representing osseous metastases.
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size has even suggested that the level of FDG avidity is corre-
lated with themalignant potential of pleural SFTs [13]. However,
larger-scale studies are needed to determine how frequently
SFT/HPCs demonstrate FDG avidity and whether those find-
ings correlate with pathologic grade as well as clinical outcomes
such as rates of metastases and survival.
In conclusion, though soft-tissue SFT/HPCs are slow-
growing mesenchymal tumors that tend to have a favorable
prognosis, their risk of local recurrence and distant metasta-
sis is non-negligible.We illustrate in this case that these tumors
can metastasize silently to soft tissues and bones many years
after initial treatment which can then be detected by FDG-
PET/CT, though they can be missed on other common imaging
modalities due to their indolent nature. This case highlights
the need for additional research that examines the role of
nuclear medicine in the surveillance and follow-up of these
SFT/HPCs given the known long-term risk of distant metas-
tases regardless of tumor histology.
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